Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ICAgen researchers patent new potassium channel blockers

Aug. 23, 1999

WHI-P164, a potential treatment for atherosclerosis in patients with hyperlipidemia, hypertension

Aug. 23, 1999

CV Therapeutics reports initial results from ranolazine trial

Aug. 23, 1999

Selective ETB receptor antagonist identified by Abbott

Aug. 18, 1999

Results of canine study support conivaptan efficacy in CHF

Aug. 18, 1999

Cordox shows cardioprotective effect during prolonged ischemia

Aug. 17, 1999

Endovasc reaches liposomal VEGF development agreement with Hermes Biosciences

Aug. 17, 1999

ACES will evaluate azithromycin in heart disease

Aug. 16, 1999

Ibutilide is effective in conversion of atrial arrhythmia secondary to cardiac surgery

Aug. 12, 1999

Incara, Knoll terminate Bextra collaboration

Aug. 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...